Oxford Genetics, a supplier of synthetic biology-based technologies for biologics discovery, development, and delivery, has secured a contract with a multi-billion dollar global e-commerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering platform for CRISPR modification of mammalian…